Cargando…

Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism

Non-alcoholic fatty liver disease (NAFLD) is a systemic and wide-spread disease characterized by accumulation of excess fat in the liver of people who drink little or no alcohol. Artificial sweeteners (ASs) or sugar substitutes are food additives that provide a sweet taste, and are also known as low...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emamat, Hadi, Ghalandari, Hamid, Tangestani, Hadith, Abdollahi, Afsoun, Hekmatdoost, Azita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257251/ https://www.ncbi.nlm.nih.gov/pubmed/32483408 http://dx.doi.org/10.17179/excli2020-1226

Ejemplares similares

Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study
por: Emamat, Hadi, et al.
Publicado: (2021)

The association between epicardial adipose tissue and non-alcoholic fatty liver disease: A systematic review of existing human studies
por: Emamat, Hadi, et al.
Publicado: (2021)

Association between dietary acid load and the odds of ulcerative colitis: a case–control study
por: Movahedian, Mina, et al.
Publicado: (2023)

Role of Dietary Approaches to Stop Hypertension Diet in Risk of Metabolic Syndrome: Evidence from Observational and Interventional Studies
por: Farhadnejad, Hossein, et al.
Publicado: (2021)

The Association between Nuts Intake and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: a Case-Control Study
por: Asbaghi, Omid, et al.
Publicado: (2020)

Red and Processed Meat Intake in Relation to Non-Alcoholic Fatty Liver Disease Risk: Results from a Case-Control Study
por: Rahimi-Sakak, Fatemeh, et al.
Publicado: (2022)

Vitamin D and The Gut Microbiota: a Narrative Literature Review
por: Tangestani, Hadith, et al.
Publicado: (2021)

An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease
por: Emamat, Hadi, et al.
Publicado: (2016)

Effect of barberry (Berberis vulgaris) consumption on blood pressure, plasma lipids, and inflammation in patients with hypertension and other cardiovascular risk factors: study protocol for a randomized clinical trial
por: Emamat, Hadi, et al.
Publicado: (2020)

The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease
por: Emamat, Hadi, et al.
Publicado: (2016)

Variants in Circadian Rhythm Gene Cry1 Interacts with Healthy Dietary Pattern for Serum Leptin Levels: a Cross-sectional Study
por: Tangestani, Hadith, et al.
Publicado: (2021)

Interaction of Cry1 Gene Polymorphisms and Dominant Food Patterns on Obesity: A Cross-Sectional Study
por: Tangestani, Hadith, et al.
Publicado: (2022)

Egg consumption and risk of non-alcoholic fatty liver disease
por: Mokhtari, Zeinab, et al.
Publicado: (2017)

Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats
por: Amirinejad, Ali, et al.
Publicado: (2021)

Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
por: Abbas, Tahany, et al.
Publicado: (2020)

Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease
por: Mansour, Asieh, et al.
Publicado: (2023)

Nutrient patterns and non-alcoholic fatty liver disease in Iranian Adul: A case-control study
por: Salehi-sahlabadi, Ammar, et al.
Publicado: (2022)

Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in mice
por: Wang, Qihan, et al.
Publicado: (2021)

Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice
por: Liu, Yaming, et al.
Publicado: (2022)

Adherence to oxidative balance scores and lower odds of non-alcoholic fatty liver disease: a case–control study
por: Sohouli, Mohammad Hassan, et al.
Publicado: (2023)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

The effect of daily consumption of different doses of fortified Lavash bread versus plain bread on serum vitamin-D status, body composition, metabolic and inflammatory biomarkers, and gut microbiota in apparently healthy adult: study protocol of a randomized clinical trial
por: Tangestani, Hadith, et al.
Publicado: (2019)

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
por: Mouzaki, Marialena, et al.
Publicado: (2016)

Dietary Total Antioxidant Capacity and Risk of Non-Alcoholic Fatty Liver Disease: A Case‐Control Study
por: Salehi-Sahlabadi, Ammar, et al.
Publicado: (2020)

Sugar-Sweetened Beverages and Artificially Sweetened Beverages Consumption and the Risk of Nonalcoholic Fatty Liver (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Tseng, Tung-Sung, et al.
Publicado: (2023)

Gut microbiota dysbiosis involves in host non-alcoholic fatty liver disease upon pyrethroid pesticide exposure
por: Li, Meng, et al.
Publicado: (2022)

Comments on “The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease”
por: Cheraghpour, Makan, et al.
Publicado: (2016)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019)

Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Salavatizadeh, Marieh, et al.
Publicado: (2023)

Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2020)

Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
por: Yari, Zahra, et al.
Publicado: (2023)

Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Saadati, Saeede, et al.
Publicado: (2018)

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
por: Saltzman, Emma T., et al.
Publicado: (2018)

The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis
por: Rodriguez-Palacios, Alexander, et al.
Publicado: (2018)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
por: Naseri, Kaveh, et al.
Publicado: (2022)

Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
por: Jiang, Weiwei, et al.
Publicado: (2015)

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
por: Darabi, Zahra, et al.
Publicado: (2019)

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

Microbiome dysbiosis and alcoholic liver disease(☆)
por: Li, Fengyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5g0jfs45svadt46a88m4ojdd9g